REFERENCES
- Begg EJ, Barclay ML. Aminoglycosides—50 years on. Br J Clin Pharmacol 1995; 39: 597–603
- Klein J, Koren G, McLeod SM. Comparison methods for prediction of nephrotoxicity during development. Dev Pharmacol 1992; 19: 80–89
- Parlakpinar H, Koç M, Polat A, et al. Protective effect of aminoguanidine against nephrotoxicity induced by amikacin in rats. Urol Res 2004; 32: 278–282
- Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156–1164
- Auroma OI, Halliwell B, Hoey BM. The antioxidant action of n-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. J Free Radicals Biol Med 1989; 6: 593–597
- Harrison PM, Wendon YA, Gimson AES. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Eng J Med 1991; 324: 1852–1857
- Sener G, Sehirli AO, Dulger GA. Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J Pineal Res 2003; 35: 61–68
- Gava AL, Peotta VA, Cabral AM, Meyrelles SS, Vasquez EC. Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac hypertrophy. Auton Neurosci 2004; 114: 47–54
- Houghton DC, Plamp III CE, Defehr JM, Bennett WM, Porter G, Gilbert D. Gentamicin and tobramycin nephrotoxicity: a morphologic and functional comparison in the rat. Am J Pathol 1978; 93: 137–151
- Dimari J, Megyesi J, Udvarhelyi N, et al. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272: 292–298
- Tariq M, Morais C, Sobki A, et al. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 1999; 14: 923–929
- Andrews NP, Prasad A, Quyymi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001; 37: 117–123
- Cotgrease I, Moldeus P, Schuppe I. The metabolism of N‐acetylcysteine by human endothelial cells. Biochem Pharmacol 1991; 42: 13–16
- Walker PD, Bari Y, Shah SV. Oxidant mechanisms in gentamicin nephrotoxicity. Ren Fail 1999; 21: 433–442
- Bates DE, Beaumont SJ, Baylis BW. Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother 2002; 36: 446–451
- Low W, Dazert S, Baird A, Ryan AF. Basic fibroblast growth factor (FGF-2) protects rat cochlear hair cells in organotypical culture from aminoglycoside injury. J Cell Physiol 1996; 167: 443–450
- Walker PD, Shah SV. Reactive oxygen metabolites in endotoxin-induced acute renal failure in rats. Kidney Int 1990; 38: 1125–1132
- Guidet B, Shah SV. Enhanced in vivo H2O2 generation by rat kidney in glycerol-induced renal failure. Am J Physiol 1989; 257: F440–F445
- Guidet BR, Shah SV. In vivo generation of hydrogen peroxide by rat kidney cortex and glomeruli. Am J Physiol 1989; 256: F158–F164
- Mazzon E, Britti D, Sarro AD, Caputi AP, Cuzzocrea S. Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats. Eur J Phar 2001; 424: 75–83
- Nakajima T, Hishida A, Kato A. Mechanism for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am J Physiol 1994; 266: 425–431
- Galley HF, Howdle PD, Walker BE. The effect of intravenous antioxidants in patients with septic shock. Free Radical Biol Med 1997; 23: 768–774
- Schillier HJ, Reilly PM, Bulkley GB. Antioxidant therapy. Crit Care Med 1993; 21: 92–102